This list is an analysis based on recent market events. It's not an investment recommendation.
HEM Pharma Inc. operates as a microbiome healthcare company in South Korea and internationally. The company offers health functional food products, such as Nutrilite and my LAB microbiome solution. It also engages in the personalized analysis service and CDMO businesses. The company was founded in 2016 and is based in Pohang, South Korea.
FAQs
What is HEM Pharma stock price today?▼
The current price of 376270.KQ is ₩26,000 KRW — it has decreased by -0.95% in the past 24 hours. Watch HEM Pharma stock price performance more closely on the chart.
What is HEM Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange HEM Pharma stocks are traded under the ticker 376270.KQ.
Is HEM Pharma stock price growing?▼
376270.KQ stock has fallen by -7.96% compared to the previous week, the month change is a -25.18% fall, over the last year HEM Pharma has showed a -9.09% decrease.
What is HEM Pharma market cap?▼
Today HEM Pharma has the market capitalization of 186.58B
When is the next HEM Pharma earnings date?▼
HEM Pharma is going to release the next earnings report on November 27, 2026.
What is HEM Pharma revenue for the last year?▼
HEM Pharma revenue for the last year amounts to 4.94B KRW.
What is HEM Pharma net income for the last year?▼
376270.KQ net income for the last year is -4.04B KRW.
How many employees does HEM Pharma have?▼
As of November 3, 2026, the company has 59 employees.
In which sector is HEM Pharma located?▼
HEM Pharma operates in the Other sector.
When did HEM Pharma complete a stock split?▼
HEM Pharma has not had any recent stock splits.
Where is HEM Pharma headquartered?▼
HEM Pharma is headquartered in Pohang, South Korea.